MarketCap
Facebook
X
Telegram
Puma Biotechnology Operating Cycle | PBYI
Annual Operating Cycle Puma Biotechnology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113 | 108 | 102 | 96.9 | 72.1 | 74.8 | 70.2 | 59.6 | 260 | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 260 | 59.6 | 106 |
Quarterly Operating Cycle Puma Biotechnology
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 118 | 109 | 132 | - | 65.2 | 120 | 136 | - | 94.7 | 96.6 | 90.9 | - | 42.3 | 43 | 120 | - | 119 | 48.5 | 41.3 | 44.4 | 77.6 | 33 | 48.5 | 41.9 | 46.8 | 80 | 56 | 26.7 | 56.7 | 64.5 | 54.1 | 40.8 | 267 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 267 | 26.7 | 79.8 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - |  Russia |
 |
Brickell Biotech
BBI
|
26 | - | -5.38 % | $ 6.06 M |  USA |
 |
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
107 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
18.6 | - | - | $ 5.78 B |  Niderland |
 |
Alnylam Pharmaceuticals
ALNY
|
86.7 | $ 156.5 | -2.85 % | $ 20.5 B | USA |
 |
Amgen
AMGN
|
282 | $ 462.71 | -3.3 % | $ 249 B | USA |
 |
Theratechnologies
THTX
|
456 | - | - | $ 83.9 M |  Canada |
 |
Iovance Biotherapeutics
IOVA
|
214 | $ 7.72 | -11.26 % | $ 2.76 M | USA |
 |
Biogen
BIIB
|
402 | $ 243.85 | -4.17 % | $ 35.7 B | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
492 | $ 4.03 | 6.9 % | $ 652 M | USA |
 |
MannKind Corporation
MNKD
|
457 | $ 3.77 | -4.07 % | $ 1.15 B | USA |
 |
Insmed Incorporated
INSM
|
400 | $ 108.79 | -1.1 % | $ 21.7 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
81.3 | - | -3.76 % | $ 3.47 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
66.2 | $ 227.25 | -3.16 % | $ 13.9 B |  Irlanda |
 |
Bristol-Myers Squibb Company
BMY
|
153 | $ 63.15 | -1.64 % | $ 128 B | USA |
 |
Johnson & Johnson
JNJ
|
223 | $ 272.47 | -1.4 % | $ 656 B | USA |
 |
Kala Pharmaceuticals
KALA
|
729 | $ 0.15 | -13.14 % | $ 1.22 M | USA |
 |
Prothena Corporation plc
PRTA
|
6.97 | $ 7.9 | -5.84 % | $ 425 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
279 | $ 14.53 | -1.63 % | $ 12.1 B |  India |
 |
Crinetics Pharmaceuticals
CRNX
|
554 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Lineage Cell Therapeutics
LCTX
|
19.2 | $ 0.98 | -4.85 % | $ 226 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
361 | $ 298.8 | -5.48 % | $ 5.78 B | USA |
 |
Longeveron
LGVN
|
28.6 | $ 1.76 | -1.12 % | $ 30.9 B | USA |
 |
Eli Lilly and Company
LLY
|
433 | $ 1 366.97 | -3.62 % | $ 1.23 T | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
19.1 K | - | -15.15 % | $ 60.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
263 | - | - | $ 521 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
233 | $ 4.01 | -5.2 % | $ 48.9 M |  Israel |
 |
Compugen Ltd.
CGEN
|
400 | $ 1.94 | -4.68 % | $ 181 M | Israel |